ey0018.15-7 | (1) | ESPEYB18
Newsome Philip N
, Buchholtz Kristine
, Cusi Kenneth
, Linder Martin
, Okanoue Takeshi
, Ratziu Vlad
, Sanyal Arun J
, Sejling Anne-Sophie
, Harrison Stephen A
N Engl J Med 2021; 384:11131124. DOI: 10.1056/NEJMoa2028395 https://www.nejm.org/doi/full/10.1056/NEJMoa2028395The authors report a 72-week, double-blind placebo-controlled trial in 320 adult patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and liver fibrosis (stage F1, F2, or F3). Patients were randomly assig...